Annual Report 2024
The National Centre for Asbestos Related Diseases (NCARD) is proud to release its 2024 Annual Report. This year’s report highlights our research achievements, including: Discovery of blood biomarkers that can…
Your Gift, Their Hope: NCARD Biobank Donors Drive Lifesaving Discoveries
More than 3,000 donors and their families have helped shape new tests, treatments and hope for the future. For over 30 years, the NCARD Biobank has quietly underpinned some of…
Expert honoured for research and treatment of mesothelioma
An expert in mesothelioma from The University of Western Australia has been honoured with a prestigious award in recognition of his contribution to patient care, innovation in treatment and development…
Trial increases survival rates for mesothelioma patients
A breakthrough clinical trial has found that combining a new drug with chemotherapy treatment improved survival rates of malignant mesothelioma patients. The study, published in JAMA Oncology, was led by…
NCARD Researcher, A/Prof Alec Redwood, Wins NIH Grant
We are thrilled to announce recent grant success for the National Centre for Asbestos Related Diseases (NCARD) and our very own A/Prof Alec Redwood. Alec, a recognized expert in the…
NCARD’s Annual Scientific Symposium Sheds Light on Mesothelioma Breakthroughs
The National Centre for Asbestos Related Diseases (NCARD) recently hosted its annual Scientific Symposium, a hallmark event that united top experts in mesothelioma research. The day was filled with discussions…
Annual Report 2022
Welcome to the release of our latest annual report, where we present a comprehensive overview of the impactful work undertaken by the National Centre for Asbestos Related Diseases (NCARD) over…
Immunologist making a difference for asbestos sufferers awarded
A molecular immunologist from The University of Western Australia with a distinguished track record in researching asbestos related cancer has been presented with a prestigious award by the Asbestos Diseases…
NCARD 3MT 2021
Congratulations to all of the NCARD PhD students for fantastic 3 Minute Thesis (3MT) presentations at the 2021 Annual Scientific Meeting. As anyone who has considered the 3MT, a competition…
NCARD Annual Scientific Meeting & Public Lecture
The 14th NCARD Annual Scientific Meeting was held on 16 & 17 September 2021 in the McCusker Auditorium of the Perkins Institute of Medical Research, and included a Public Lecture…
TOGA Podcast: Dreaming of Better Treatments for Mesothelioma
In this podcast from the Thoracic Oncology Group of Australasia (TOGA), Professor Anna Nowak, Pro Vice Chancellor at UWA, Medical Oncologist and Director of the National Centre for Asbestos Related…
NCARD wins CRE funding again
We are thrilled to announce that NCARD has once again been successful in its application to the key Australian federal government funding body the National Health & Medical Research Council…
Portrait fundraiser for mesothelioma research
Hayley Caddy is an Adelaide based artist who lost her father to mesothelioma almost ten years ago. She is using her considerable talents to hold an unusual fundraiser, painting 100…
Cancer Council of WA and NCARD: fundraising and scholarships
NCARD Relay For Life team Not content with sitting in the laboratory DOING cancer research, NCARD fielded a team of walkers (and runners!) for the Relay for Life held on…
Asbestos Review Program marks 30th anniversary
The Asbestos Review Program (ARP) came tantalisingly close to having 5000 participants to coincide with its milestone anniversary in 2020, a year in which it was not always certain that…
Welcome Tanya Ward, Program Manager
Tanya Ward joined NCARD at the end of October as a Program Manager, a change which, in 2020, also meant a 14 day quarantine. Here she gives us some background.…